GLENMEDE TRUST CO NA - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$20,000
-4.8%
440
+4.8%
0.00%
Q2 2020$21,000
+200.0%
420
+268.4%
0.00%
Q1 2020$7,0000.0%1140.0%0.00%
Q4 2019$7,000
-22.2%
114
-36.7%
0.00%
Q3 2019$9,000
-30.8%
180
+4.0%
0.00%
Q2 2019$13,000
+160.0%
173
+203.5%
0.00%
Q1 2019$5,000
+25.0%
570.0%0.00%
Q4 2018$4,000
-81.8%
57
-94.3%
0.00%
Q2 2016$22,000
-24.1%
1,0000.0%0.00%
Q1 2016$29,000
-12.1%
1,0000.0%0.00%
Q4 2015$33,000
-95.5%
1,000
-95.0%
0.00%
-100.0%
Q3 2015$729,000
+1556.8%
20,200
+1920.0%
0.01%
Q2 2015$44,000
+46.7%
1,0000.0%0.00%
Q1 2015$30,000
-99.9%
1,000
-99.8%
0.00%
-100.0%
Q4 2014$20,768,000
+60.2%
408,476
+24.7%
0.16%
+43.0%
Q3 2014$12,962,000
+33.7%
327,655
+45.5%
0.11%
+31.0%
Q2 2014$9,696,000
+24761.5%
225,169
+22416.9%
0.09%
Q1 2014$39,000
+44.4%
1,0000.0%0.00%
Q4 2013$27,000
+22.7%
1,0000.0%0.00%
Q3 2013$22,000
+29.4%
1,0000.0%0.00%
Q2 2013$17,0001,0000.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders